Workboat Indexes

Bayer Aktienges ADR (OP: BAYRY )

7.450 +0.020 (+0.27%)

Streaming Delayed Price Updated: 11:51 AM EDT, Jul 30, 2024 Add to My Watchlist

Price and Volume

Volume	281,481
Open	7.480
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	7.430
Today's Range	7.390 - 7.500
52wk Range	6.820 - 14.70
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer

July 25, 2024

Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe.

Via Benzinga

ScottsMiracle-Gro Stock Blooms After Investor Day Optimism

July 23, 2024

Lawn and garden products manufacturer ScottsMiracle-Gro Co. (NYSE: SMG) stock surged on its Investor Day update ahead of fiscal Q3 2024 earnings release.

Via MarketBeat

Performance

YTD	-20.57%	-20.57%
1 Month	+6.89%	+6.89%
3 Month	+0.27%	+0.27%
6 Month	-11.20%	-11.20%
1 Year	-48.97%	-48.97%

More News

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs

July 08, 2024

Via InvestorPlace

3 Small-Cap Stocks With Explosive 2X Growth Potential

July 08, 2024

Via InvestorPlace

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M

June 05, 2024

Via Benzinga

Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership

June 01, 2024

Via Talk Markets

European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?

May 27, 2024

Via Benzinga

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February

May 24, 2024

Via Benzinga

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 2024

Via Benzinga

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

May 16, 2024

Via Benzinga

BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024

May 14, 2024

Via InvestorPlace

From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch

May 10, 2024

Via Benzinga

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned

May 02, 2024

Via Benzinga

Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'

April 10, 2024

Via Benzinga

Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists

April 09, 2024

Via Benzinga

Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds

April 05, 2024

Via Benzinga

Bayer-Backed Boundless Bio Falls After IPO

March 31, 2024

Via Talk Markets

Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms

March 19, 2024

Via AB Newswire

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant

March 19, 2024

Via Benzinga

German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits

March 14, 2024

Via Benzinga

BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023

March 05, 2024

Via InvestorPlace

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges

March 05, 2024

Via Benzinga

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

March 04, 2024

Via InvestorPlace

What's Going On With BridgeBio Pharma Stock On Monday?

March 04, 2024

Via Benzinga

BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?

March 04, 2024

Via Investor's Business Daily

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.